Recent progress in breast cancer management. Combined modality (adjuvant) therapy
Cowan, K.; Lippman, M.
Archives of Internal Medicine 141(8): 1055-1059
1981
ISSN/ISBN: 0003-9926 PMID: 7018440 Document Number: 181634
Document emailed within 1 workday
Related Documents
Minsky, B.D. 1999: Adjuvant postoperative combined-modality therapy for rectal cancer Oncology 13(7 Suppl 3: 132-135Abe, R.; Tsuchiya, A.; Koie, H.; Ono, K.; Abo, S.; Saito, K.; Tsukamoto, M.; Sato, T.; Mori, S.; Motoki, R. 1988: Cooperative research on post-operative adjuvant therapy of breast cancer. Tohoku Society of Adjuvant Chemo-endocrine Therapy of Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(9): 2707-2712
Chahine, G.; Howayek, M.; Atallah, D. 2009: Adjuvant endocrine therapy in breast cancer. Management of early-risk relapse Le Journal Medical Libanais. Lebanese Medical Journal 57(2): 124-129
Pichatechaiyoot, A.; Buhachat, R.; Boonyapipat, S.; Kanjanapradit, K. 2014: Radiation, chemotherapy or combined modality therapy in adjuvant treatment for stage IIi endometrial carcinoma in lower southern Thailand: disease recurrence and overall survival Journal of the Medical Association of Thailand 97(3): 274-282
Yoshida, M.; Saji, S.; Takagi, H.; Takeuchi, S.; Tsuda, H.; Nimura, Y.; Mizumoto, R.; Miyazaki, I.; Kobayashi, S.; Noguchi, M. 1993: A comparative study among ftorafur, ftorafur plus tamoxifen, and tamoxifen in adjuvant therapy for breast cancer. the Chubu Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer, Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(15): 2325-2333
Neoptolemos, J.P.; Baker, P.; Beger, H.; Link, K.; Pederzoli, P.; Bassi, C.; Dervenis, C.; Friess, H.; Büchler, M. 1997: Progress report. A randomized multicenter European study comparing adjuvant radiotherapy, 6-mo chemotherapy, and combination therapy vs no-adjuvant treatment in resectable pancreatic cancer (ESPAC-1) International Journal of Pancreatology: Official Journal of the International Association of Pancreatology 21(2): 97-104
Panettiere, F.J. 1983: Chemotherapy and combined modality therapy in the management of large bowel adenocarcinomas Journal of the Arkansas Medical Society 79(9): 311-314
Swain, S.M.; Sorace, R.A.; Bagley, C.S.; Danforth, D.N.; Bader, J.; Wesley, M.N.; Steinberg, S.M.; Lippman, M.E. 1987: Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer Cancer Research 47(14): 3889-3894
Donegan, W.L. 1992: Recent trends in the management of breast cancer. 3. Controversies in the use of adjuvant chemotherapy, hormonotherapy and radiotherapy for breast cancer Canadian Journal of Surgery. Journal Canadien de Chirurgie 35(4): 371-377
Cho, L.C.; Choy, H. 2004: Topoisomerase i inhibitors in the combined-modality therapy of lung cancer Oncology 18(7 Suppl 4: 29-39
Castiglione-Gertsch, M.; Tattersall, M.; Hacking, A.; Goldhirsch, A.; Gudgeon, A.; Gelber, R.D.; Lindtner, J.; Coates, A.; Collins, J.; Isley, M.; Senn, H.J.; Rudenstam, C.M. 1997: Retreating recurrent breast cancer with the same CMF-containing regimen used as adjuvant therapy. The International Breast Cancer Study Group European Journal of Cancer 33(14): 2321-2325
Mitchell, E.P. 2000: Irinotecan in preoperative combined-modality therapy for locally advanced rectal cancer Oncology 14(12 Suppl. 14): 56-59
Sunose, Y.; Takeyoshi, I.; Hirai, K.; Igarashi, T.; Takahashi, K.; Yamazaki, H.; Tanaka, K.; Takahashi, N.; Tsukagoshi, H.; Ogawa, H.; Yoshinari, D.; Yokoo, H. 2015: A case of advanced pancreas cancer successfully treated by using combined modality therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(2): 241-244
Tominaga, T.; Abe, O.; Izuo, M.; Isono, K.; Enomoto, K.; Nishi, M.; Fukami, A.; Muto, T.; Morioka, Y.; Watanabe, H. 1993: Correlations between estrogen receptor and prognostic factors of patients with breast cancer. the Kanto Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer, Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(14): 2171-2176
Mitsuyama, S.; Kuroda, Y.; Ohsato, K.; Nakamura, Y.; Murakami, F.; Nishikata, F.; Ikeda, S.; Egami, T.; Mori, A.; Ohe, H. 1996: Administration method and recurrence-preventing effect of medroxyprogesterone acetate (MPA) as a postoperative adjuvant endocrine therapy for stage III breast cancer. Kitakyushu Collaborative Study Group for Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(9): 1153-1160
Hasegawa, H.; Hashimoto, T.; Nakamura, T.; Kitagawa, M.; Kudo, K.; Shoji, F.; Kabashima, A.; Teramoto, S.; Kitamura, M. 2012: A case of long-term survival due to combined modality therapy for liver metastasis of colon cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(12): 2234-2236
Fukino, N.; Kida, K.; Kuboi, Y.; Mimatsu, K.; Amano, S. 2016: Report of a Successful Case of Combined Modality Therapy for a Patient with Local Recurrence of Rectal Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(12): 2157-2159
Coppin, C.M.; Goldie, J.H. 1994: Adjuvant therapy for breast cancer New England Journal of Medicine 331(11): 742; Author Reply 744-745
Melnychuk, D.; Panasci, L.C. 1994: Adjuvant therapy for breast cancer New England Journal of Medicine 331(11): 741
Garey, J.; Lehrer, S. 1994: Adjuvant therapy for breast cancer New England Journal of Medicine 331(11): 742